MeSH tree: C06.405.469.158.188.231
In a study published in Science Advances, Dr. Shai Bel and his research team at the Azrieli Faculty of Medicine of Bar-Ilan University have uncovered crucial insights into how antibiotic use increases the risk of inflammatory ...
Sep 11, 2024
0
71
Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed a probiotic-based therapeutic that synergistically restores intestinal redox and microbiota homeostasis. This therapeutic ...
Aug 28, 2024
0
54
Helping people with inflammatory bowel diseases to get a better night's sleep could help keep the condition at bay and improve their quality of life, say Flinders University and Flinders Medical Center researchers, as they ...
Aug 26, 2024
0
37
A healthy gut helps lower your risk of developing inflammatory diseases such as inflammatory bowel disease (IBD), a chronic condition that causes inflammation in the digestive tract.
Aug 16, 2024
0
778
Removing a nuclear bile acid receptor that regulates glucose and lipid stability from the intestine blocks gut inflammation in mice, according to researchers at Children's Hospital Los Angeles. Their findings are published ...
Aug 15, 2024
0
59
Ulcerative colitis (UC) is an inflammatory bowel disease that causes irritation, inflammation, and ulcers in the tissues lining the large intestine. Known to be a long-term condition, UC can result in significant discomfort, ...
Aug 12, 2024
0
44
Almost 2.4 million Americans are thought to suffer from the pain and disability of inflammatory bowel disorder (IBD), a type of autoimmune illness that includes ulcerative colitis and Crohn's disease.
Aug 6, 2024
0
262
A newly developed imaging method, granzyme B PET, can non-invasively detect inflammatory bowel disease (IBD) and provide a real-time picture of active inflammation in the tissue, according to new research published in the ...
Jul 25, 2024
0
43
Monoclonal antibodies have become indispensable in medicine to combat cancers, infectious diseases and autoimmune disorders. But the mechanism of action of a major monoclonal antibody developed for ulcerative colitis has ...
Subcutaneous delivery of an anti-TNF inhibitor drug improved remission rates in patients with moderate-to-severe Crohn's disease and ulcerative colitis, according to recent phase 3 clinical trial results published in the ...
Jul 16, 2024
0
46
